Dry amorphisation of mangiferin, a poorly water-soluble compound, using mesoporous silica

[Display omitted] Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous silica to enhance the solubility of mangiferin. The amorphous samples were prepared by mixing 1:1 (w/w) Syloid® XDP 3050 silica-mangiferin mixt...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutics and biopharmaceutics Vol. 141; pp. 172 - 179
Main Authors Baán, Adrienn, Adriaensens, Peter, Lammens, Joris, Delgado Hernandez, René, Vanden Berghe, Wim, Pieters, Luc, Vervaet, Chris, Kiekens, Filip
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous silica to enhance the solubility of mangiferin. The amorphous samples were prepared by mixing 1:1 (w/w) Syloid® XDP 3050 silica-mangiferin mixtures using a planetary mono mill at different milling speeds and milling times according to a 32 full factorial experimental design. The prepared samples were characterized for dissolution profile, particle size distribution using laser diffraction particle size analyzer, thermal characteristics using DSC, crystalline characteristics using XRD and molecular interactions using FTIR and ss-NMR. The samples were tested for stability at stress conditions (40 °C/75%RH) for up to 6 months in open and closed containers. To improve stability of the samples, mixtures of 1:1:2 mangiferin-polymer (Soluplus or HPMC)-silica samples were also prepared and analyzed. Amorphisation of mangiferin is possible using dry amorphisation by ball milling with mesoporous silica in a short amount of time. The amorphisation rate of the samples improved with the energy input of the milling process. The samples prepared with high energy input resulted in amorphous samples and showed a better stability at the stress conditions for up to 3 months. Solubility of these samples increased from 0.32 to 0.50 mg/ml and the particle size decreased from 35.5 µm to around 7 µm. The spectral analysis suggest presence of interactions between the silica material and the compound. The amorphous stability was improved with addition of polymer, even though the solubility of the samples was lower.
AbstractList Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous silica to enhance the solubility of mangiferin. The amorphous samples were prepared by mixing 1:1 (w/w) Syloid® XDP 3050 silica-mangiferin mixtures using a planetary mono mill at different milling speeds and milling times according to a 3 full factorial experimental design. The prepared samples were characterized for dissolution profile, particle size distribution using laser diffraction particle size analyzer, thermal characteristics using DSC, crystalline characteristics using XRD and molecular interactions using FTIR and ss-NMR. The samples were tested for stability at stress conditions (40 °C/75%RH) for up to 6 months in open and closed containers. To improve stability of the samples, mixtures of 1:1:2 mangiferin-polymer (Soluplus or HPMC)-silica samples were also prepared and analyzed. Amorphisation of mangiferin is possible using dry amorphisation by ball milling with mesoporous silica in a short amount of time. The amorphisation rate of the samples improved with the energy input of the milling process. The samples prepared with high energy input resulted in amorphous samples and showed a better stability at the stress conditions for up to 3 months. Solubility of these samples increased from 0.32 to 0.50 mg/ml and the particle size decreased from 35.5 µm to around 7 µm. The spectral analysis suggest presence of interactions between the silica material and the compound. The amorphous stability was improved with addition of polymer, even though the solubility of the samples was lower.
[Display omitted] Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous silica to enhance the solubility of mangiferin. The amorphous samples were prepared by mixing 1:1 (w/w) Syloid® XDP 3050 silica-mangiferin mixtures using a planetary mono mill at different milling speeds and milling times according to a 32 full factorial experimental design. The prepared samples were characterized for dissolution profile, particle size distribution using laser diffraction particle size analyzer, thermal characteristics using DSC, crystalline characteristics using XRD and molecular interactions using FTIR and ss-NMR. The samples were tested for stability at stress conditions (40 °C/75%RH) for up to 6 months in open and closed containers. To improve stability of the samples, mixtures of 1:1:2 mangiferin-polymer (Soluplus or HPMC)-silica samples were also prepared and analyzed. Amorphisation of mangiferin is possible using dry amorphisation by ball milling with mesoporous silica in a short amount of time. The amorphisation rate of the samples improved with the energy input of the milling process. The samples prepared with high energy input resulted in amorphous samples and showed a better stability at the stress conditions for up to 3 months. Solubility of these samples increased from 0.32 to 0.50 mg/ml and the particle size decreased from 35.5 µm to around 7 µm. The spectral analysis suggest presence of interactions between the silica material and the compound. The amorphous stability was improved with addition of polymer, even though the solubility of the samples was lower.
Author Adriaensens, Peter
Kiekens, Filip
Lammens, Joris
Delgado Hernandez, René
Vervaet, Chris
Baán, Adrienn
Pieters, Luc
Vanden Berghe, Wim
Author_xml – sequence: 1
  givenname: Adrienn
  surname: Baán
  fullname: Baán, Adrienn
  email: adrienn.baan@uantwerpen.be
  organization: University of Antwerp, Department of Pharmaceutical Technology and Biopharmacy, Universiteitsplein 1 2610 Wilrijk, Belgium
– sequence: 2
  givenname: Peter
  surname: Adriaensens
  fullname: Adriaensens, Peter
  email: peter.adriaensens@uhasselt.be
  organization: University of Hasselt, Institute for Materials Research, Agoralaan Building D, 3590 Diepenbeek, Belgium
– sequence: 3
  givenname: Joris
  surname: Lammens
  fullname: Lammens, Joris
  organization: Ghent University, Laboratory of Pharmaceutical Technology, Ottergemsesteenweg 460, 9000 Ghent, Belgium
– sequence: 4
  givenname: René
  surname: Delgado Hernandez
  fullname: Delgado Hernandez, René
  email: rene.delgado@cidem.sld.cu
  organization: Universidad de la Habana, Instituto de Farmacia y Alimentos, 222 La Habana, Cuba
– sequence: 5
  givenname: Wim
  surname: Vanden Berghe
  fullname: Vanden Berghe, Wim
  email: wim.vandenberghe@uantwerpen.be
  organization: University of Antwerp, Department of Biomedical Sciences, Universiteitsplein 1 2610 Wilrijk, Belgium
– sequence: 6
  givenname: Luc
  surname: Pieters
  fullname: Pieters, Luc
  email: luc.pieters@uantwerpen.be
  organization: University of Antwerp, Department of Pharmaceutical Sciences, Universiteitsplein 1 2610 Wilrijk, Belgium
– sequence: 7
  givenname: Chris
  surname: Vervaet
  fullname: Vervaet, Chris
  email: chris.vervaet@ugent.be
  organization: Ghent University, Laboratory of Pharmaceutical Technology, Ottergemsesteenweg 460, 9000 Ghent, Belgium
– sequence: 8
  givenname: Filip
  surname: Kiekens
  fullname: Kiekens, Filip
  email: filip.kiekens@uantwerpen.be
  organization: University of Antwerp, Department of Pharmaceutical Technology and Biopharmacy, Universiteitsplein 1 2610 Wilrijk, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31150810$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtOwzAURC1URB_wAyyQP6AJ98aJ20hsUHlKldjAgpXlOHZxlMSRnYD696QqsGQ1mzmj0ZmTSetaTcglQoyA_LqKddUVcQKYx5DFkPATMsP1ikUsTXFCZpCzPOIp4pTMQ6gAIF1l6zMyZYgZrBFm5P3O76lsnO8-bJC9dS11hjay3VmjvW2XVNLOOV_v6ZfstY-Cq4ei1lS5pnNDWy7pEGy7o40OrnPeDYEGW1slz8mpkXXQFz-5IG8P96-bp2j78vi8ud1GKgXoIwSueGJ4iQyTQuYZH9PIRPJSMVipFZpUyiTjRqcSGeQqKbICTFEyydka2YIkx13lXQheG9F520i_Fwji4ElU4uBJHDwJyMToaYSujlA3FI0u_5BfMWPh5ljQ4_VPq70IyupW6dJ6rXpROvvf_jdiz3xJ
CitedBy_id crossref_primary_10_1016_j_ejps_2021_106015
crossref_primary_10_2174_1567201819666220721111852
crossref_primary_10_1016_j_ejpb_2021_04_004
crossref_primary_10_3390_molecules28155918
crossref_primary_10_1016_j_ijpharm_2023_122717
crossref_primary_10_1016_j_ejpb_2022_08_010
crossref_primary_10_1016_j_ijbiomac_2021_01_001
crossref_primary_10_3389_fphar_2021_670167
crossref_primary_10_5802_crchim_82
crossref_primary_10_3390_molecules28083406
crossref_primary_10_1016_j_jddst_2020_101733
crossref_primary_10_1016_j_jddst_2024_105698
crossref_primary_10_1021_acs_molpharmaceut_0c00811
crossref_primary_10_1080_10408398_2021_1983767
Cites_doi 10.1351/pac198557040603
10.1016/j.powtec.2019.02.010
10.1039/b707322d
10.1016/j.addr.2007.05.012
10.1016/j.ssc.2006.02.007
10.1007/s11095-013-1075-7
10.1016/j.jddst.2015.01.002
10.1016/j.jsps.2013.05.004
10.1517/17425247.2.1.335
10.1080/10717540601098823
10.1016/j.addr.2007.05.010
10.1007/978-1-4939-1598-9_23
10.1007/s11095-006-9062-x
10.1002/biof.1292
10.1016/j.ejpb.2011.08.005
10.1016/j.ajps.2014.12.006
10.1002/jps.23678
10.1186/s12944-017-0449-y
10.1016/j.ijpharm.2017.03.078
10.1070/RC2006v075n03ABEH001205
10.1002/jps.23966
10.1016/j.ejpb.2012.02.004
10.1016/j.canlet.2011.02.011
10.1080/10837450802012869
10.1007/s10847-008-9456-y
ContentType Journal Article
Copyright 2019 Elsevier B.V.
Copyright © 2019. Published by Elsevier B.V.
Copyright_xml – notice: 2019 Elsevier B.V.
– notice: Copyright © 2019. Published by Elsevier B.V.
DBID NPM
AAYXX
CITATION
DOI 10.1016/j.ejpb.2019.05.026
DatabaseName PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
DatabaseTitleList PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3441
EndPage 179
ExternalDocumentID 10_1016_j_ejpb_2019_05_026
31150810
S0939641119302619
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SES
SEW
SPCBC
SSP
SSU
SSZ
T5K
TEORI
UNMZH
~G-
AAXKI
AKRWK
NPM
AAYXX
AFJKZ
CITATION
ID FETCH-LOGICAL-c400t-106c62f6d1312ba956312fa2a6dc307c71f4aa256fe4a1309c2b5b0fbd3a63813
IEDL.DBID AIKHN
ISSN 0939-6411
IngestDate Thu Sep 26 17:04:27 EDT 2024
Wed Oct 16 00:51:49 EDT 2024
Fri Feb 23 02:36:42 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Solubility improvement
Solid dispersions
Drug formulation
Dry amorphisation
Mesoporous silica
Co-milling
Language English
License Copyright © 2019. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c400t-106c62f6d1312ba956312fa2a6dc307c71f4aa256fe4a1309c2b5b0fbd3a63813
OpenAccessLink https://repository.uantwerpen.be/docman/irua/d1e2f8/159943.2020_05_30
PMID 31150810
PageCount 8
ParticipantIDs crossref_primary_10_1016_j_ejpb_2019_05_026
pubmed_primary_31150810
elsevier_sciencedirect_doi_10_1016_j_ejpb_2019_05_026
PublicationCentury 2000
PublicationDate 2019-08-01
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle European journal of pharmaceutics and biopharmaceutics
PublicationTitleAlternate Eur J Pharm Biopharm
PublicationYear 2019
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References García-Rivera, Delgado, Bougarne, Haegeman, Vanden Berghe (b0110) 2011; 305
Maggi, Canobbio, Bruni, Musitelli, Conte (b0090) 2015; 26
Paudel, Geppi, Van Den Mooter (b0025) 2014; 103
Loh, Samanta, Sia Heng (b0155) 2014; 10
Brewster, Loftsson (b0040) 2007; 59
ICH Harmonized Tripartite Guideline: Stability testing of New Drug Substances and Products Q1A (R2), in: Int. Conf. Harmon. Tech. Requir. Regist. Pharm. Hum. Use, 2003.
Sing, Everett, Haul, Moscou, Pierotti, Rouquérol, Siemieniewska (b0060) 1985; 57
Limnell, Heikkilä, Santos, Sistonen, Hellstén, Laaksonen, Peltonen, Kumar, Murzin, Louhi-Kultanen, Salonen, Hirvonen, Lehto (b0070) 2011; 416
Löbmann, Strachan, Grohganz, Rades, Korhonen, Laitinen (b0085) 2012; 81
Boldyrev (b0160) 2006; 75
Bahl, Bogner (b0100) 2006; 23
Heikkilä, Salonen, Tuura, Kumar, Salmi, Murzin, Hamdy, Mul, Laitinen, Kaukonen, Hirvonen, Lehto (b0075) 2007; 14
Branham, Moyo, Govender (b0150) 2012; 80
Buntkowsky, Breitzke, Adamczyk, Roelofs, Emmler, Gedat, Grünberg, Xu, Limbach, Shenderovich, Vyalikh, Findenegg (b0165) 2007; 9
Dudognon, Willart, Caron, Capet, Larsson, Descamps (b0080) 2006; 138
Douroumis, Fahr (b0050) 2013
Imran, Arshad, Butt, Kwon, Arshad, Sultan (b0115) 2017; 16
Serajuddin (b0010) 2007; 59
Moore, Flanner (b0130) 1996; 20
Lieberman, Vemuri (b0015) 2015
Sandler, Genina, Wisaeus, Rantanen, Raijada, Peltonen, Fors (b0135) 2013; 102
Vyas, Saraf, Saraf (b0045) 2008; 62
Loftsson, Jarho, Másson, Järvinen, Publications (b0035) 2005; 2
Liu, Tong, He, Wang, Lei, Du, Xie, Wang (b0105) 2018
Bahl, Hudak, Bogner (b0095) 2008; 13
Szafraniec, Antosik, Knapik-Kowalczuk, Kurek, Syrek, Chmiel, Paluch, Jachowicz (b0140) 2017; 533
Vandana, Prasanna Raju, Harini Chowdary, Sushma, Vijay Kumar (b0030) 2014; 22
Vogt, Roberts-Skilton, Kennedy-Gabb (b0065) 2013; 30
Choudhari, Hoefer, Libanati, Monsuur, Mccarthy (b0055) 2014
Jain (b0005) 2014
Saha, Sadhukhan, Sil, Mangiferin (b0120) 2016; 42
Bikiaris (b0020) 2014
Nowak, Krupa, Kubat, Węgrzyn, Harańczyk, Ciułkowska, Jachowicz (b0145) 2019; 346
Moore (10.1016/j.ejpb.2019.05.026_b0130) 1996; 20
Bahl (10.1016/j.ejpb.2019.05.026_b0100) 2006; 23
Limnell (10.1016/j.ejpb.2019.05.026_b0070) 2011; 416
Saha (10.1016/j.ejpb.2019.05.026_b0120) 2016; 42
Lieberman (10.1016/j.ejpb.2019.05.026_b0015) 2015
Serajuddin (10.1016/j.ejpb.2019.05.026_b0010) 2007; 59
10.1016/j.ejpb.2019.05.026_b0125
Buntkowsky (10.1016/j.ejpb.2019.05.026_b0165) 2007; 9
Bahl (10.1016/j.ejpb.2019.05.026_b0095) 2008; 13
Szafraniec (10.1016/j.ejpb.2019.05.026_b0140) 2017; 533
Dudognon (10.1016/j.ejpb.2019.05.026_b0080) 2006; 138
Choudhari (10.1016/j.ejpb.2019.05.026_b0055) 2014
Löbmann (10.1016/j.ejpb.2019.05.026_b0085) 2012; 81
Boldyrev (10.1016/j.ejpb.2019.05.026_b0160) 2006; 75
García-Rivera (10.1016/j.ejpb.2019.05.026_b0110) 2011; 305
Liu (10.1016/j.ejpb.2019.05.026_b0105) 2018
Vogt (10.1016/j.ejpb.2019.05.026_b0065) 2013; 30
Sandler (10.1016/j.ejpb.2019.05.026_b0135) 2013; 102
Douroumis (10.1016/j.ejpb.2019.05.026_b0050) 2013
Jain (10.1016/j.ejpb.2019.05.026_b0005) 2014
Maggi (10.1016/j.ejpb.2019.05.026_b0090) 2015; 26
Vandana (10.1016/j.ejpb.2019.05.026_b0030) 2014; 22
Heikkilä (10.1016/j.ejpb.2019.05.026_b0075) 2007; 14
Vyas (10.1016/j.ejpb.2019.05.026_b0045) 2008; 62
Paudel (10.1016/j.ejpb.2019.05.026_b0025) 2014; 103
Nowak (10.1016/j.ejpb.2019.05.026_b0145) 2019; 346
Imran (10.1016/j.ejpb.2019.05.026_b0115) 2017; 16
Loh (10.1016/j.ejpb.2019.05.026_b0155) 2014; 10
Brewster (10.1016/j.ejpb.2019.05.026_b0040) 2007; 59
Bikiaris (10.1016/j.ejpb.2019.05.026_b0020) 2014
Loftsson (10.1016/j.ejpb.2019.05.026_b0035) 2005; 2
Branham (10.1016/j.ejpb.2019.05.026_b0150) 2012; 80
Sing (10.1016/j.ejpb.2019.05.026_b0060) 1985; 57
References_xml – volume: 16
  start-page: 1
  year: 2017
  end-page: 17
  ident: b0115
  article-title: Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
  publication-title: Lipids Health Dis.
  contributor:
    fullname: Sultan
– volume: 305
  start-page: 21
  year: 2011
  end-page: 31
  ident: b0110
  article-title: Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells
  publication-title: Cancer Lett.
  contributor:
    fullname: Vanden Berghe
– volume: 62
  start-page: 23
  year: 2008
  end-page: 42
  ident: b0045
  article-title: Cyclodextrin based novel drug delivery systems
  publication-title: J. Incl. Phenom. Macrocycl. Chem.
  contributor:
    fullname: Saraf
– volume: 346
  start-page: 373
  year: 2019
  end-page: 384
  ident: b0145
  article-title: Water vapour sorption in tadalafil-Soluplus co-milled amorphous solid dispersions
  publication-title: Powder Technol.
  contributor:
    fullname: Jachowicz
– start-page: 665
  year: 2014
  end-page: 693
  ident: b0055
  article-title: Mesoporous silica drug delivery systems
  publication-title: Amorph. Solid Dispersions.
  contributor:
    fullname: Mccarthy
– year: 2013
  ident: b0050
  article-title: Drug delivery strategies for poorly water-soluble drugs
  contributor:
    fullname: Fahr
– volume: 26
  start-page: 17
  year: 2015
  end-page: 23
  ident: b0090
  article-title: Improvement of the dissolution behavior of gliclazide, a slightly soluble drug, using solid dispersions
  publication-title: J. Drug Deliv. Sci. Technol.
  contributor:
    fullname: Conte
– volume: 13
  start-page: 255
  year: 2008
  end-page: 269
  ident: b0095
  article-title: Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding
  publication-title: Pharm. Dev. Technol.
  contributor:
    fullname: Bogner
– volume: 138
  start-page: 68
  year: 2006
  end-page: 71
  ident: b0080
  article-title: Formation of budesonide/α-lactose glass solutions by ball-milling
  publication-title: Solid State Commun.
  contributor:
    fullname: Descamps
– volume: 533
  start-page: 470
  year: 2017
  end-page: 479
  ident: b0140
  article-title: Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Jachowicz
– volume: 23
  start-page: 2317
  year: 2006
  end-page: 2325
  ident: b0100
  article-title: Amorphization of indomethacin by Co-grinding with neusilin US2: amorphization kinetics, physical stability and mechanism
  publication-title: Pharm. Res.
  contributor:
    fullname: Bogner
– volume: 14
  start-page: 337
  year: 2007
  end-page: 347
  ident: b0075
  article-title: Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
  publication-title: Drug Delivery
  contributor:
    fullname: Lehto
– year: 2014
  ident: b0005
  article-title: Current Status and Future Prospects of Drug Delivery Systems
  contributor:
    fullname: Jain
– volume: 80
  start-page: 194
  year: 2012
  end-page: 202
  ident: b0150
  article-title: Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Govender
– volume: 2
  start-page: 329
  year: 2005
  end-page: 357
  ident: b0035
  article-title: Expert opinion on drug delivery cyclodextrins in drug delivery
  publication-title: Exp. Opin. Drug Deliv.
  contributor:
    fullname: Publications
– start-page: 4775
  year: 2018
  end-page: 4786
  ident: b0105
  article-title: Mangiferin: an effective therapeutic agent against several disorders (Review)
  publication-title: Mol. Med. Rep.
  contributor:
    fullname: Wang
– year: 2014
  ident: b0020
  article-title: Solid dispersions part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs
  publication-title: Exp. Opin. Drug Deliv.
  contributor:
    fullname: Bikiaris
– volume: 20
  start-page: 64
  year: 1996
  end-page: 75
  ident: b0130
  article-title: Mathematical comparison of dissolution profiles
  publication-title: Pharm. Technol.
  contributor:
    fullname: Flanner
– volume: 30
  start-page: 2315
  year: 2013
  end-page: 2331
  ident: b0065
  article-title: A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica
  publication-title: Pharm. Res.
  contributor:
    fullname: Kennedy-Gabb
– volume: 416
  start-page: 242
  year: 2011
  end-page: 251
  ident: b0070
  article-title: Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Lehto
– volume: 57
  start-page: 603
  year: 1985
  end-page: 619
  ident: b0060
  article-title: Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity
  publication-title: Pure Appl. Chem.
  contributor:
    fullname: Siemieniewska
– volume: 81
  start-page: 159
  year: 2012
  end-page: 169
  ident: b0085
  article-title: Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Laitinen
– volume: 10
  start-page: 255
  year: 2014
  end-page: 274
  ident: b0155
  article-title: Overview of milling techniques for improving the solubility of poorly water-soluble drugs
  publication-title: Asian J. Pharm. Sci.
  contributor:
    fullname: Sia Heng
– year: 2015
  ident: b0015
  article-title: Chemical and Physicochemical Approaches to Solve Formulation Problems
  contributor:
    fullname: Vemuri
– volume: 75
  start-page: 177
  year: 2006
  end-page: 189
  ident: b0160
  article-title: Mechanochemistry and mechanical activation of solids
  publication-title: Russ. Chem. Rev.
  contributor:
    fullname: Boldyrev
– volume: 22
  start-page: 283
  year: 2014
  end-page: 289
  ident: b0030
  article-title: An overview on in situ micronization technique – an emerging novel concept in advanced drug delivery
  publication-title: Saudi Pharm. J.
  contributor:
    fullname: Vijay Kumar
– volume: 59
  start-page: 645
  year: 2007
  end-page: 666
  ident: b0040
  article-title: Cyclodextrins as pharmaceutical solubilizers
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Loftsson
– volume: 59
  start-page: 603
  year: 2007
  end-page: 616
  ident: b0010
  article-title: Salt formation to improve drug solubility
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Serajuddin
– volume: 103
  start-page: 2635
  year: 2014
  end-page: 2662
  ident: b0025
  article-title: Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Van Den Mooter
– volume: 102
  start-page: 3694
  year: 2013
  end-page: 3704
  ident: b0135
  article-title: A step toward development of printable dosage forms for poorly soluble drugs
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Fors
– volume: 9
  start-page: 4843
  year: 2007
  end-page: 4853
  ident: b0165
  article-title: Structural and dynamical properties of guest molecules confined in mesoporous silica materials revealed by NMR
  publication-title: Phys. Chem. Chem. Phys.
  contributor:
    fullname: Findenegg
– volume: 42
  start-page: 459
  year: 2016
  end-page: 474
  ident: b0120
  article-title: A xanthonoid with multipotent anti-inflammatory potential
  publication-title: BioFactors
  contributor:
    fullname: Mangiferin
– volume: 57
  start-page: 603
  year: 1985
  ident: 10.1016/j.ejpb.2019.05.026_b0060
  article-title: Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity
  publication-title: Pure Appl. Chem.
  doi: 10.1351/pac198557040603
  contributor:
    fullname: Sing
– volume: 346
  start-page: 373
  year: 2019
  ident: 10.1016/j.ejpb.2019.05.026_b0145
  article-title: Water vapour sorption in tadalafil-Soluplus co-milled amorphous solid dispersions
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2019.02.010
  contributor:
    fullname: Nowak
– volume: 9
  start-page: 4843
  year: 2007
  ident: 10.1016/j.ejpb.2019.05.026_b0165
  article-title: Structural and dynamical properties of guest molecules confined in mesoporous silica materials revealed by NMR
  publication-title: Phys. Chem. Chem. Phys.
  doi: 10.1039/b707322d
  contributor:
    fullname: Buntkowsky
– volume: 59
  start-page: 645
  year: 2007
  ident: 10.1016/j.ejpb.2019.05.026_b0040
  article-title: Cyclodextrins as pharmaceutical solubilizers
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2007.05.012
  contributor:
    fullname: Brewster
– volume: 138
  start-page: 68
  year: 2006
  ident: 10.1016/j.ejpb.2019.05.026_b0080
  article-title: Formation of budesonide/α-lactose glass solutions by ball-milling
  publication-title: Solid State Commun.
  doi: 10.1016/j.ssc.2006.02.007
  contributor:
    fullname: Dudognon
– volume: 30
  start-page: 2315
  year: 2013
  ident: 10.1016/j.ejpb.2019.05.026_b0065
  article-title: A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-013-1075-7
  contributor:
    fullname: Vogt
– volume: 26
  start-page: 17
  year: 2015
  ident: 10.1016/j.ejpb.2019.05.026_b0090
  article-title: Improvement of the dissolution behavior of gliclazide, a slightly soluble drug, using solid dispersions
  publication-title: J. Drug Deliv. Sci. Technol.
  doi: 10.1016/j.jddst.2015.01.002
  contributor:
    fullname: Maggi
– volume: 22
  start-page: 283
  year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0030
  article-title: An overview on in situ micronization technique – an emerging novel concept in advanced drug delivery
  publication-title: Saudi Pharm. J.
  doi: 10.1016/j.jsps.2013.05.004
  contributor:
    fullname: Vandana
– volume: 2
  start-page: 329
  year: 2005
  ident: 10.1016/j.ejpb.2019.05.026_b0035
  article-title: Expert opinion on drug delivery cyclodextrins in drug delivery
  publication-title: Exp. Opin. Drug Deliv.
  doi: 10.1517/17425247.2.1.335
  contributor:
    fullname: Loftsson
– start-page: 4775
  year: 2018
  ident: 10.1016/j.ejpb.2019.05.026_b0105
  article-title: Mangiferin: an effective therapeutic agent against several disorders (Review)
  publication-title: Mol. Med. Rep.
  contributor:
    fullname: Liu
– year: 2015
  ident: 10.1016/j.ejpb.2019.05.026_b0015
  contributor:
    fullname: Lieberman
– volume: 14
  start-page: 337
  issue: 6
  year: 2007
  ident: 10.1016/j.ejpb.2019.05.026_b0075
  article-title: Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
  publication-title: Drug Delivery
  doi: 10.1080/10717540601098823
  contributor:
    fullname: Heikkilä
– volume: 59
  start-page: 603
  year: 2007
  ident: 10.1016/j.ejpb.2019.05.026_b0010
  article-title: Salt formation to improve drug solubility
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2007.05.010
  contributor:
    fullname: Serajuddin
– start-page: 665
  year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0055
  article-title: Mesoporous silica drug delivery systems
  publication-title: Amorph. Solid Dispersions.
  doi: 10.1007/978-1-4939-1598-9_23
  contributor:
    fullname: Choudhari
– year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0005
  contributor:
    fullname: Jain
– volume: 23
  start-page: 2317
  year: 2006
  ident: 10.1016/j.ejpb.2019.05.026_b0100
  article-title: Amorphization of indomethacin by Co-grinding with neusilin US2: amorphization kinetics, physical stability and mechanism
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-006-9062-x
  contributor:
    fullname: Bahl
– volume: 20
  start-page: 64
  year: 1996
  ident: 10.1016/j.ejpb.2019.05.026_b0130
  article-title: Mathematical comparison of dissolution profiles
  publication-title: Pharm. Technol.
  contributor:
    fullname: Moore
– volume: 42
  start-page: 459
  year: 2016
  ident: 10.1016/j.ejpb.2019.05.026_b0120
  article-title: A xanthonoid with multipotent anti-inflammatory potential
  publication-title: BioFactors
  doi: 10.1002/biof.1292
  contributor:
    fullname: Saha
– volume: 416
  start-page: 242
  year: 2011
  ident: 10.1016/j.ejpb.2019.05.026_b0070
  article-title: Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Limnell
– year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0020
  article-title: Solid dispersions part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs
  publication-title: Exp. Opin. Drug Deliv.
  contributor:
    fullname: Bikiaris
– volume: 80
  start-page: 194
  year: 2012
  ident: 10.1016/j.ejpb.2019.05.026_b0150
  article-title: Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2011.08.005
  contributor:
    fullname: Branham
– volume: 10
  start-page: 255
  year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0155
  article-title: Overview of milling techniques for improving the solubility of poorly water-soluble drugs
  publication-title: Asian J. Pharm. Sci.
  doi: 10.1016/j.ajps.2014.12.006
  contributor:
    fullname: Loh
– volume: 102
  start-page: 3694
  year: 2013
  ident: 10.1016/j.ejpb.2019.05.026_b0135
  article-title: A step toward development of printable dosage forms for poorly soluble drugs
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.23678
  contributor:
    fullname: Sandler
– volume: 16
  start-page: 1
  year: 2017
  ident: 10.1016/j.ejpb.2019.05.026_b0115
  article-title: Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-017-0449-y
  contributor:
    fullname: Imran
– volume: 533
  start-page: 470
  year: 2017
  ident: 10.1016/j.ejpb.2019.05.026_b0140
  article-title: Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.03.078
  contributor:
    fullname: Szafraniec
– volume: 75
  start-page: 177
  year: 2006
  ident: 10.1016/j.ejpb.2019.05.026_b0160
  article-title: Mechanochemistry and mechanical activation of solids
  publication-title: Russ. Chem. Rev.
  doi: 10.1070/RC2006v075n03ABEH001205
  contributor:
    fullname: Boldyrev
– ident: 10.1016/j.ejpb.2019.05.026_b0125
– volume: 103
  start-page: 2635
  year: 2014
  ident: 10.1016/j.ejpb.2019.05.026_b0025
  article-title: Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.23966
  contributor:
    fullname: Paudel
– volume: 81
  start-page: 159
  year: 2012
  ident: 10.1016/j.ejpb.2019.05.026_b0085
  article-title: Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2012.02.004
  contributor:
    fullname: Löbmann
– volume: 305
  start-page: 21
  year: 2011
  ident: 10.1016/j.ejpb.2019.05.026_b0110
  article-title: Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2011.02.011
  contributor:
    fullname: García-Rivera
– volume: 13
  start-page: 255
  year: 2008
  ident: 10.1016/j.ejpb.2019.05.026_b0095
  article-title: Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding
  publication-title: Pharm. Dev. Technol.
  doi: 10.1080/10837450802012869
  contributor:
    fullname: Bahl
– year: 2013
  ident: 10.1016/j.ejpb.2019.05.026_b0050
  contributor:
    fullname: Douroumis
– volume: 62
  start-page: 23
  year: 2008
  ident: 10.1016/j.ejpb.2019.05.026_b0045
  article-title: Cyclodextrin based novel drug delivery systems
  publication-title: J. Incl. Phenom. Macrocycl. Chem.
  doi: 10.1007/s10847-008-9456-y
  contributor:
    fullname: Vyas
SSID ssj0004758
Score 2.4212
Snippet [Display omitted] Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous...
Mangiferin, a poorly water soluble compound, was processed via a dry amorphisation technique (ball milling) in combination with mesoporous silica to enhance...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 172
SubjectTerms Co-milling
Drug formulation
Dry amorphisation
Mesoporous silica
Solid dispersions
Solubility improvement
Title Dry amorphisation of mangiferin, a poorly water-soluble compound, using mesoporous silica
URI https://dx.doi.org/10.1016/j.ejpb.2019.05.026
https://www.ncbi.nlm.nih.gov/pubmed/31150810
Volume 141
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5qvXgR39YXexAvNrabd46lKlWxFGxBT2GfJWKT0gfSi7_d2SS1eulBCISEbDZ8s_PY8M0MwKWjo9APqbAcqW3L9TxhhUI4VuS5QgXC1jRvB_Tc9TsD9_HVe61Ae5kLY2iVpe0vbHpurcs7jRLNxjhJGi-4F498F3U1cvKNxAZsojuywypsth6eOt1VemSQt-k0z1tmQJk7U9C81PuYG4ZXlBfwNDUW1vqnX87nfge2y6iRtIoP24WKSvfgqleUnV7USX-VRTWtkyvSWxWkXuzD2-1kQdgoQ0hL8g7JNBmxdGh4LUlaJ4yMs2zysSCfGHpOLLMe-Ycihm9u2i7ViaHHD8lITTOM17P5lEwT87fvAAb3d_12xypbKlgClXWGRtcXvq19SR1qc4abIzxrZjNfCtR2EVDtMoZhkFYuQ_cWCZt7vKm5dBhqKnUOoZpmqToGEsrIpk5APcmlGygjcCmFdJt4RD7XNbheAhmPi8oZ8ZJS9h4b2GMDe9z0YoS9Bt4S6_iP_GM07WvHHRWC-ZnDlA_COKd58s83nsKWuSpIfmdQnU3m6hwDjxm_gI2bL3pRLq9vJADX5A
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB60HvQi7tZ1DtKLDW32zrGopS4tBVuop2HWErFJ6ILk3_smSa1ePAiBQJLJhG_mvfkmfO89hG5cTVpByxaWK7Vjeb4vrJYQrkV8T6hQONrOywH1-kF35D2N_fEGulvFwhhZZen7C5-ee-vySqNEs5FGUeMV9uIk8MBWiZtvJDbRFrABAta51X587vbX4ZFhXqbTPG-ZBmXsTCHzUu8pNwovkifwNDkW_lyffiw-nT20W7JG3C4-bB9tqPgA1QZF2umsjofrKKp5HdfwYJ2QOjtEb_ezDLNpApCW4h2caDxl8cToWqK4jhlOk2T2keFPoJ4zy8xH_qGw0Zubskt1bOTxEzxV8wT4erKc43lk_vYdoVHnYXjXtcqSCpYAY12A0w1E4OhA2q7tcAabIzhr5rBACrB2EdraYwxokFYeg-WNCIf7vKm5dBlYqu0eo0qcxOoU4ZYkju2Gti-59EJlBlxKIb0mHCTguopuV0DStMicQVeSsndqYKcGdtr0KcBeRf4Ka_pr_Cm49j_bnRQD892HSR8EPKd59s83XqPt7rD3Ql8e-8_naMfcKQR_F6iymC3VJZCQBb8qJ9kXX8bZ2A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dry+amorphisation+of+mangiferin%2C+a+poorly+water-soluble+compound%2C+using+mesoporous+silica&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Ba%C3%A1n%2C+Adrienn&rft.au=Adriaensens%2C+Peter&rft.au=Lammens%2C+Joris&rft.au=Delgado+Hernandez%2C+Ren%C3%A9&rft.date=2019-08-01&rft.eissn=1873-3441&rft_id=info:doi/10.1016%2Fj.ejpb.2019.05.026&rft_id=info%3Apmid%2F31150810&rft.externalDocID=31150810
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon